Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Egle

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|September 12, 1998
Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevityA Villunger, A Egle, M Kos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphomaL Weiss, T Melchardt, S Habringer, et al.
Blood|July 1, 1997
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillanceA Villunger, A Egle, I Marschitz, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Leukemia|May 25, 2011
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLLJ Piñón Hofbauer, C Heyder, U Denk, et al.
The Pharmacogenomics Journal|January 20, 2019
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximabT Magnes, T Melchardt, C Hufnagl, et al.
The Pharmacogenomics Journal|July 19, 2017
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximabT Magnes, T Melchardt, C Hufnagl, et al.
Infection|May 6, 2011
Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in AustriaW Poeppl, M Hell, H Herkner, et al.
Leukemia|November 3, 2015
Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivoB S Hanna, F McClanahan, H Yazdanparast, et al.
British Journal of Cancer|May 31, 2014
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patientsK T Troppan, K Schlick, A Deutsch, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|September 12, 1998
Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevityA Villunger, A Egle, M Kos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphomaL Weiss, T Melchardt, S Habringer, et al.
Blood|July 1, 1997
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillanceA Villunger, A Egle, I Marschitz, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Leukemia|May 25, 2011
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLLJ Piñón Hofbauer, C Heyder, U Denk, et al.
The Pharmacogenomics Journal|January 20, 2019
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximabT Magnes, T Melchardt, C Hufnagl, et al.
The Pharmacogenomics Journal|July 19, 2017
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximabT Magnes, T Melchardt, C Hufnagl, et al.
Infection|May 6, 2011
Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in AustriaW Poeppl, M Hell, H Herkner, et al.
Leukemia|November 3, 2015
Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivoB S Hanna, F McClanahan, H Yazdanparast, et al.
British Journal of Cancer|May 31, 2014
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patientsK T Troppan, K Schlick, A Deutsch, et al.
Pageof 4